Search research articles
Contact Us
Filters
Showing results (51-60 of 67) with videos related to
Page
of 7
Sort By:
Mabs
|
January 7, 2020
Molecular mechanism of an antagonistic antibody against glucose-dependent insulinotropic polypeptide receptor
Xiaoshan Min, Junming Yie, Jinghong Wang, et al.
Journal of Molecular Biology
|
April 13, 2010
Generation of novel long-acting globular adiponectin molecules
Hongfei Ge, Yumei Xiong, Bryan Lemon, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 5, 2013
Inhibiting NF-κB-inducing kinase (NIK): discovery, structure-based design, synthesis, structure-activity relationship, and co-crystal structures
Kexue Li, Lawrence R McGee, Ben Fisher, et al.
The Journal of Biological Chemistry
|
November 28, 2012
An inhibitory antibody against dipeptidyl peptidase IV improves glucose tolerance in vivo
Jie Tang, Jiangwen Majeti, Athena Sudom, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 26, 2010
The synthesis and SAR of novel diarylsulfone 11β-HSD1 inhibitors
Xuelei Yan, Zhulun Wang, Athena Sudom, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 3, 2009
Optimization of novel di-substituted cyclohexylbenzamide derivatives as potent 11 beta-HSD1 inhibitors
Dustin L McMinn, Yosup Rew, Athena Sudom, et al.
Journal of Medicinal Chemistry
|
October 23, 2018
Discovery of Tarantula Venom-Derived Na<sub>V</sub>1.7-Inhibitory JzTx-V Peptide 5-Br-Trp24 Analogue AM-6120 with Systemic Block of Histamine-Induced Pruritis
Bin Wu, Justin K Murray, Kristin L Andrews, et al.
Journal of Medicinal Chemistry
|
June 17, 2008
Discovery of novel, potent benzamide inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) exhibiting oral activity in an enzyme inhibition ex vivo model
Lisa D Julian, Zhulun Wang, Tracy Bostick, et al.
ACS Medicinal Chemistry Letters
|
April 16, 2020
Discovery of [1,2,4]Triazolo[1,5-<i>a</i>]pyridine Derivatives as Potent and Orally Bioavailable RORγt Inverse Agonists
Ryota Nakajima, Hiroyuki Oono, Sakae Sugiyama, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 25, 2010
Synthesis and optimization of novel 4,4-disubstituted cyclohexylbenzamide derivatives as potent 11β-HSD1 inhibitors
Daqing Sun, Zhulun Wang, Seb Caille, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 67) with videos related to
Sort By:
Page
of 7
Mabs
|
January 7, 2020
Molecular mechanism of an antagonistic antibody against glucose-dependent insulinotropic polypeptide receptor
Xiaoshan Min, Junming Yie, Jinghong Wang, et al.
Journal of Molecular Biology
|
April 13, 2010
Generation of novel long-acting globular adiponectin molecules
Hongfei Ge, Yumei Xiong, Bryan Lemon, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 5, 2013
Inhibiting NF-κB-inducing kinase (NIK): discovery, structure-based design, synthesis, structure-activity relationship, and co-crystal structures
Kexue Li, Lawrence R McGee, Ben Fisher, et al.
The Journal of Biological Chemistry
|
November 28, 2012
An inhibitory antibody against dipeptidyl peptidase IV improves glucose tolerance in vivo
Jie Tang, Jiangwen Majeti, Athena Sudom, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 26, 2010
The synthesis and SAR of novel diarylsulfone 11β-HSD1 inhibitors
Xuelei Yan, Zhulun Wang, Athena Sudom, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 3, 2009
Optimization of novel di-substituted cyclohexylbenzamide derivatives as potent 11 beta-HSD1 inhibitors
Dustin L McMinn, Yosup Rew, Athena Sudom, et al.
Journal of Medicinal Chemistry
|
October 23, 2018
Discovery of Tarantula Venom-Derived Na<sub>V</sub>1.7-Inhibitory JzTx-V Peptide 5-Br-Trp24 Analogue AM-6120 with Systemic Block of Histamine-Induced Pruritis
Bin Wu, Justin K Murray, Kristin L Andrews, et al.
Journal of Medicinal Chemistry
|
June 17, 2008
Discovery of novel, potent benzamide inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) exhibiting oral activity in an enzyme inhibition ex vivo model
Lisa D Julian, Zhulun Wang, Tracy Bostick, et al.
ACS Medicinal Chemistry Letters
|
April 16, 2020
Discovery of [1,2,4]Triazolo[1,5-<i>a</i>]pyridine Derivatives as Potent and Orally Bioavailable RORγt Inverse Agonists
Ryota Nakajima, Hiroyuki Oono, Sakae Sugiyama, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 25, 2010
Synthesis and optimization of novel 4,4-disubstituted cyclohexylbenzamide derivatives as potent 11β-HSD1 inhibitors
Daqing Sun, Zhulun Wang, Seb Caille, et al.
Page
of 7